Auxilium pharmaceuticals, inc. announces fourth quarter and full year 2009 financial results, guidance for 2010 and ... (marketwire)

2010-02-17 | Source

Full Year 2009 Net Revenues Increase by 30.8% to a Record $164.0 Million; 2010 Testim(R) Revenues Expected to Be in the Range of $185 Million to $195 Million; XIAFLEX(TM) List Price to Distributors Will Be $3,250.00 per Vial